{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T15:31:23Z","timestamp":1795102283596,"version":"4.10.3"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007150","name":"United Therapeutics Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Without aggressive treatment, pulmonary arterial hypertension (PAH) has a 5-year mortality of approximately 40%. A patient\u2019s response to vasodilators at diagnosis impacts the therapeutic options and prognosis. We hypothesized that analyzing perfusion images acquired before and during vasodilation could identify characteristic differences between PAH and control subjects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We studied 5 controls and 4 subjects with PAH using HRCT and\n                      <jats:sup>13<\/jats:sup>\n                      NN PET imaging of pulmonary perfusion and ventilation. The total spatial heterogeneity of perfusion (CV\n                      <jats:sup>2<\/jats:sup>\n                      <jats:sub>Qtotal<\/jats:sub>\n                      ) and its components in the vertical (CV\n                      <jats:sup>2<\/jats:sup>\n                      <jats:sub>Qvgrad<\/jats:sub>\n                      ) and cranio-caudal (CV\n                      <jats:sup>2<\/jats:sup>\n                      <jats:sub>Qzgrad<\/jats:sub>\n                      ) directions, and the residual heterogeneity (CV\n                      <jats:sup>2<\/jats:sup>\n                      <jats:sub>Qr<\/jats:sub>\n                      ), were assessed at baseline and while breathing oxygen and nitric oxide (O\n                      <jats:sub>2<\/jats:sub>\n                      \u2009+\u2009iNO). The length scale spectrum of CV\n                      <jats:sup>2<\/jats:sup>\n                      <jats:sub>Qr<\/jats:sub>\n                      was determined from 10 to 110\u00a0mm, and the response of regional perfusion to O\n                      <jats:sub>2<\/jats:sub>\n                      \u2009+\u2009iNO was calculated as the mean of absolute differences. Vertical gradients in perfusion (Q\n                      <jats:sub>vgrad<\/jats:sub>\n                      ) were derived from perfusion images, and ventilation-perfusion distributions from images of\n                      <jats:sup>13<\/jats:sup>\n                      NN washout kinetics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      O\n                      <jats:sub>2<\/jats:sub>\n                      \u2009+\u2009iNO significantly enhanced perfusion distribution differences between PAH and controls, allowing differentiation of PAH subjects from controls. During O\n                      <jats:sub>2<\/jats:sub>\n                      \u2009+\u2009iNO, CV\n                      <jats:sup>2<\/jats:sup>\n                      <jats:sub>Qvgrad<\/jats:sub>\n                      was significantly higher in controls than in PAH (0.08 (0.055\u20130.10) vs. 6.7\u2009\u00d7\u200910\n                      <jats:sup>\u20133<\/jats:sup>\n                      (2\u2009\u00d7\u200910\n                      <jats:sup>\u20134<\/jats:sup>\n                      \u20130.02), p\u2009&lt;\u20090.001) with a considerable gap between groups. Q\n                      <jats:sub>vgrad<\/jats:sub>\n                      and CV\n                      <jats:sup>2<\/jats:sup>\n                      <jats:sub>Qtotal<\/jats:sub>\n                      showed smaller differences: \u2212\u20097.3 vs. \u2212\u20092.5, p\u2009=\u20090.002, and 0.12 vs. 0.06, p\u2009=\u20090.01. CV\n                      <jats:sup>2<\/jats:sup>\n                      <jats:sub>Qvgrad<\/jats:sub>\n                      had the largest effect size among the primary parameters during O\n                      <jats:sub>2<\/jats:sub>\n                      \u2009+\u2009iNO. CV\n                      <jats:sup>2<\/jats:sup>\n                      <jats:sub>Qr<\/jats:sub>\n                      , and its length scale spectrum were similar in PAH and controls. Ventilation-perfusion distributions showed a trend towards a difference between PAH and controls at baseline, but it was not statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Perfusion imaging during O2\u2009+\u2009iNO showed a significant difference in the heterogeneity associated with the vertical gradient in perfusion, distinguishing in this small cohort study PAH subjects from controls.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-022-02239-8","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:14:47Z","timestamp":1669900487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Perfusion imaging heterogeneity during NO inhalation distinguishes pulmonary arterial hypertension (PAH) from healthy subjects and has potential as an imaging biomarker"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7276-5550","authenticated-orcid":false,"given":"Tilo","family":"Winkler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina G.","family":"Kehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison S.","family":"Witkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josanna M.","family":"Rodriguez-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7908-5446","authenticated-orcid":false,"given":"Kathryn A.","family":"Hibbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamary T.","family":"Kone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9610-6330","authenticated-orcid":false,"given":"David M.","family":"Systrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7797-0361","authenticated-orcid":false,"given":"Aaron B.","family":"Waxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose G.","family":"Venegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard N.","family":"Channick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Scott","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"2239_CR1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1164\/rccm.201207-1266ED","volume":"186","author":"T Thenappan","year":"2012","unstructured":"Thenappan T, Ryan JJ, Archer SL. Evolving epidemiology of pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186:707\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"2239_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.healun.2014.10.003","volume":"34","author":"SJ Halliday","year":"2015","unstructured":"Halliday SJ, Hemnes AR, Robbins IM, Pugh ME, Zhao DX, Piana RN, et al. Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the \u201cclassic\u201d responders. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2015;34:312\u20138.","journal-title":"J Heart Lung Transplant Off Publ Int Soc Heart Transplant"},{"key":"2239_CR3","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"N Gali\u00e8","year":"2015","unstructured":"Gali\u00e8 N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46:903\u201375.","journal-title":"Eur Respir J"},{"key":"2239_CR4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4103\/2045-8932.83449","volume":"1","author":"R Malhotra","year":"2011","unstructured":"Malhotra R, Hess D, Lewis GD, Bloch KD, Waxman AB, Semigran MJ. Vasoreactivity to inhaled nitric oxide with oxygen predicts long-term survival in pulmonary arterial hypertension. Pulm Circ. 2011;1:250\u20138.","journal-title":"Pulm Circ"},{"key":"2239_CR5","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1152\/japplphysiol.00223.2002","volume":"93","author":"G Musch","year":"2002","unstructured":"Musch G, Layfield JDH, Harris RS, Melo MFV, Winkler T, Callahan RJ, et al. Topographical distribution of pulmonary perfusion and ventilation, assessed by PET in supine and prone humans. J Appl Physiol. 2002;93:1841\u201351.","journal-title":"J Appl Physiol"},{"key":"2239_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1152\/japplphysiol.00292.2007","volume":"103","author":"GK Prisk","year":"2007","unstructured":"Prisk GK, Yamada K, Henderson AC, Arai TJ, Levin DL, Buxton RB, et al. Pulmonary perfusion in the prone and supine postures in the normal human lung. J Appl Physiol. 2007;103:883\u201394.","journal-title":"J Appl Physiol"},{"key":"2239_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1152\/japplphysiol.01289.2006","volume":"103","author":"SR Hopkins","year":"2007","unstructured":"Hopkins SR, Henderson AC, Levin DL, Yamada K, Arai T, Buxton RB, et al. Vertical gradients in regional lung density and perfusion in the supine human lung: the Slinky effect. J Appl Physiol. 2007;103:240\u20138.","journal-title":"J Appl Physiol"},{"key":"2239_CR8","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.acra.2005.06.004","volume":"12","author":"KS Burrowes","year":"2005","unstructured":"Burrowes KS, Hunter PJ, Tawhai MH. Investigation of the relative effects of vascular branching structure and gravity on pulmonary arterial blood flow heterogeneity via an image-based computational model. Acad Radiol. 2005;12:1464\u201374.","journal-title":"Acad Radiol"},{"key":"2239_CR9","first-page":"182","volume":"14","author":"MP Hlastala","year":"1999","unstructured":"Hlastala MP, Glenny RW. Vascular structure determines pulmonary blood flow distribution. Physiol Am Physiol Soc. 1999;14:182\u20136.","journal-title":"Physiol Am Physiol Soc"},{"key":"2239_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF01951755","volume":"46","author":"TR Nelson","year":"1990","unstructured":"Nelson TR, West BJ, Goldberger AL. The fractal lung: universal and species-related scaling patterns. Experientia. 1990;46:251\u20134.","journal-title":"Experientia"},{"key":"2239_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0002-9440(10)65137-1","volume":"155","author":"CD Cool","year":"1999","unstructured":"Cool CD, Stewart JS, Werahera P, Miller GJ, Williams RL, Voelkel NF, et al. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Am J Pathol. 1999;155:411\u20139.","journal-title":"Am J Pathol"},{"key":"2239_CR12","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1164\/rccm.201810-1899LE","volume":"199","author":"P Kohli","year":"2019","unstructured":"Kohli P, Kelly VJ, Kehl EG, Rodriguez-Lopez J, Hibbert KA, Kone M, et al. Perfusion imaging distinguishes exercise pulmonary arterial hypertension at rest. Am J Respir Crit Care Med. 2019;199:1438\u201341.","journal-title":"Am J Respir Crit Care Med"},{"key":"2239_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1161\/01.CIR.66.3.621","volume":"66","author":"M Horn","year":"1982","unstructured":"Horn M, Hooper W, Brach B, Ashburn W, Moser K. Postural changes in pulmonary blood flow in pulmonary hypertension: a noninvasive technique using ventilation-perfusion scans. Circulation. 1982;66:621\u20136.","journal-title":"Circulation"},{"key":"2239_CR14","first-page":"47","volume":"100","author":"EM Lau","year":"2014","unstructured":"Lau EM, Bailey DL, Bailey EA, Torzillo PJ, Roach PJ, Schembri GP, et al. Pulmonary hypertension leads to a loss of gravity dependent redistribution of regional lung perfusion: a SPECT\/CT study. Heart Br Card Soc. 2014;100:47\u201353.","journal-title":"Heart Br Card Soc"},{"key":"2239_CR15","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1007\/s00330-022-08577-x","volume":"32","author":"B Lefebvre","year":"2022","unstructured":"Lefebvre B, Kyheng M, Giordano J, Lamblin N, de Groote P, Fertin M, et al. Dual-energy CT lung perfusion characteristics in pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and\/or pulmonary capillary hemangiomatosis (PVOD\/PCH): preliminary experience in 63 patients. Eur Radiol. 2022;32:4574\u201386.","journal-title":"Eur Radiol"},{"key":"2239_CR16","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s00330-016-4500-6","volume":"27","author":"J Giordano","year":"2017","unstructured":"Giordano J, Khung S, Duhamel A, Hossein-Foucher C, Bell\u00e8vre D, Lamblin N, et al. Lung perfusion characteristics in pulmonary arterial hypertension (PAH) and peripheral forms of chronic thromboembolic pulmonary hypertension (pCTEPH): dual-energy CT experience in 31 patients. Eur Radiol. 2017;27:1631\u20139.","journal-title":"Eur Radiol"},{"key":"2239_CR17","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1093\/oxfordjournals.eurheartj.a061593","volume":"5","author":"P Wollmer","year":"1984","unstructured":"Wollmer P, Rozkovec A, Rhodes CG, Allan RM, Maseri A. Regional pulmonary blood volume in patients with abnormal blood pressure or flow in the pulmonary circulation. Eur Heart J. 1984;5:924\u201331.","journal-title":"Eur Heart J"},{"key":"2239_CR18","doi-asserted-by":"publisher","first-page":"e0248214","DOI":"10.1371\/journal.pone.0248214","volume":"16","author":"ALD Hovnanian","year":"2021","unstructured":"Hovnanian ALD, Costa ELV, Hoette S, Fernandes CJCS, Jardim CVP, Dias BA, et al. Electrical impedance tomography in pulmonary arterial hypertension. PLoS ONE. 2021;16:e0248214.","journal-title":"PLoS ONE"},{"key":"2239_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1183\/09031936.03.00033803","volume":"23","author":"AT Jones","year":"2004","unstructured":"Jones AT, Hansell DM, Evans TW. Quantifying pulmonary perfusion in primary pulmonary hypertension using electron-beam computed tomography. Eur Respir J. 2004;23:202\u20137.","journal-title":"Eur Respir J"},{"key":"2239_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrcardio.2014.191","volume":"12","author":"EMT Lau","year":"2015","unstructured":"Lau EMT, Humbert M, Celermajer DS. Early detection of pulmonary arterial hypertension. Nat Rev Cardiol. 2015;12:143\u201355.","journal-title":"Nat Rev Cardiol"},{"key":"2239_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1152\/japplphysiol.01354.2013","volume":"118","author":"AK Asadi","year":"2015","unstructured":"Asadi AK, S\u00e1 RC, Kim NH, Theilmann RJ, Hopkins SR, Buxton RB, et al. Inhaled nitric oxide alters the distribution of blood flow in the healthy human lung, suggesting active hypoxic pulmonary vasoconstriction in normoxia. J Appl Physiol. 2015;118:331\u201343.","journal-title":"J Appl Physiol"},{"key":"2239_CR22","first-page":"1982","volume":"44","author":"MF Vidal Melo","year":"2003","unstructured":"Vidal Melo MF, Layfield D, Harris RS, O\u2019Neill K, Musch G, Richter T, et al. Quantification of regional ventilation-perfusion ratios with PET. J Nucl Med. 2003;44:1982\u201391.","journal-title":"J Nucl Med"},{"key":"2239_CR23","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1152\/japplphysiol.01631.2011","volume":"113","author":"TJ Wellman","year":"2012","unstructured":"Wellman TJ, Winkler T, Costa ELV, Musch G, Harris RS, Venegas JG, et al. Effect of regional lung inflation on ventilation heterogeneity at different length scales during mechanical ventilation of normal sheep lungs. J Appl Physiol. 2012;113:947\u201357.","journal-title":"J Appl Physiol"},{"key":"2239_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1164\/rccm.200510-1634OC","volume":"174","author":"RS Harris","year":"2006","unstructured":"Harris RS, Winkler T, Tgavalekos N, Musch G, Melo MFV, Schroeder T, et al. Regional pulmonary perfusion, inflation, and ventilation defects in bronchoconstricted patients with asthma. Am J Respir Crit Care Med. 2006;174:245\u201353.","journal-title":"Am J Respir Crit Care Med"},{"key":"2239_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2967\/jnumed.109.065185","volume":"51","author":"MF Vidal Melo","year":"2010","unstructured":"Vidal Melo MF, Winkler T, Harris RS, Musch G, Greene RE, Venegas JG. Spatial heterogeneity of lung perfusion assessed with 13N PET as a vascular biomarker in chronic obstructive pulmonary disease. J Nucl Med. 2010;51:57\u201365.","journal-title":"J Nucl Med"},{"key":"2239_CR26","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1164\/rccm.201612-2438OC","volume":"196","author":"VJ Kelly","year":"2017","unstructured":"Kelly VJ, Hibbert KA, Kohli P, Kone M, Greenblatt EE, Venegas JG, et al. Hypoxic pulmonary vasoconstriction does not explain all regional perfusion redistribution in asthma. Am J Respir Crit Care Med. 2017;196:834\u201344.","journal-title":"Am J Respir Crit Care Med"},{"key":"2239_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123417","volume":"10","author":"T Winkler","year":"2015","unstructured":"Winkler T, Melo MFV, Degani-Costa LH, Harris RS, Correia JA, Musch G, et al. Estimation of noise-free variance to measure heterogeneity. PLoS ONE. 2015;10: e0123417.","journal-title":"PLoS ONE"},{"key":"2239_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.acra.2018.02.028","volume":"26","author":"G Motta-Ribeiro","year":"2019","unstructured":"Motta-Ribeiro G, Winkler T, Hashimoto S, Vidal Melo MF. Spatial heterogeneity of lung strain and aeration and regional inflammation during early lung injury assessed with PET\/CT. Acad Radiol. 2019;26:313\u201325.","journal-title":"Acad Radiol"},{"key":"2239_CR29","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1164\/rccm.201710-2038OC","volume":"198","author":"GC Motta-Ribeiro","year":"2018","unstructured":"Motta-Ribeiro GC, Hashimoto S, Winkler T, Baron RM, Grogg K, Paula LFSC, et al. Deterioration of regional lung strain and inflammation during early lung injury. Am J Respir Crit Care Med. 2018;198:891\u2013902.","journal-title":"Am J Respir Crit Care Med"},{"key":"2239_CR30","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria; 2022. https:\/\/www.R-project.org\/"},{"key":"2239_CR31","unstructured":"Torchiano M. Effsize\u2014a package for efficient effect size computation. Zenodo; 2016. https:\/\/zenodo.org\/record\/1480624. Accessed 4 May 2022."},{"key":"2239_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1152\/jappl.1960.15.3.405","volume":"15","author":"JB West","year":"1960","unstructured":"West JB, Dollery CT. Distribution of blood flow and ventilation-perfusion ratio in the lung, measured with radioactive CO2. J Appl Physiol. 1960;15:405\u201310.","journal-title":"J Appl Physiol"},{"key":"2239_CR33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1152\/jappl.1979.46.3.419","volume":"46","author":"SJ Lai-Fook","year":"1979","unstructured":"Lai-Fook SJ. A continuum mechanics analysis of pulmonary vascular interdependence in isolated dog lobes. J Appl Physiol. 1979;46:419\u201329.","journal-title":"J Appl Physiol"},{"key":"2239_CR34","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.jacc.2004.02.033","volume":"43","author":"GG Pietra","year":"2004","unstructured":"Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IM, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol. 2004;43:S25-32.","journal-title":"J Am Coll Cardiol"},{"key":"2239_CR35","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.jacc.2009.04.017","volume":"54","author":"RJ Barst","year":"2009","unstructured":"Barst RJ, Gibbs JSR, Ghofrani HA, Hoeper MM, McLaughlin VV, Rubin LJ, et al. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54:S78-84.","journal-title":"J Am Coll Cardiol"},{"key":"2239_CR36","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ccm.2013.08.009","volume":"34","author":"RM Tuder","year":"2013","unstructured":"Tuder RM, Stacher E, Robinson J, Kumar R, Graham BB. Pathology of pulmonary hypertension. Clin Chest Med. 2013;34:639\u201350.","journal-title":"Clin Chest Med"},{"key":"2239_CR37","doi-asserted-by":"publisher","first-page":"e13159","DOI":"10.14814\/phy2.13159","volume":"5","author":"N Rol","year":"2017","unstructured":"Rol N, Timmer EM, Faes TJC, Vonk Noordegraaf A, Gr\u00fcnberg K, Bogaard H-J, et al. Vascular narrowing in pulmonary arterial hypertension is heterogeneous: rethinking resistance. Physiol Rep. 2017;5:e13159.","journal-title":"Physiol Rep"},{"key":"2239_CR38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1164\/rccm.201201-0164OC","volume":"186","author":"E Stacher","year":"2012","unstructured":"Stacher E, Graham BB, Hunt JM, Gandjeva A, Groshong SD, McLaughlin VV, et al. Modern age pathology of pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186:261\u201372.","journal-title":"Am J Respir Crit Care Med"},{"key":"2239_CR39","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1152\/japplphysiol.90759.2008","volume":"106","author":"TJ Arai","year":"2009","unstructured":"Arai TJ, Henderson AC, Dubowitz DJ, Levin DL, Friedman PJ, Buxton RB, et al. Hypoxic pulmonary vasoconstriction does not contribute to pulmonary blood flow heterogeneity in normoxia in normal supine humans. J Appl Physiol. 2009;106:1057\u201364.","journal-title":"J Appl Physiol"},{"key":"2239_CR40","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1152\/japplphysiol.01092.2007","volume":"104","author":"M Hughes","year":"2008","unstructured":"Hughes M, West JB. Point:Counterpoint: gravity is\/is not the major factor determining the distribution of blood flow in the human lung. J Appl Physiol. 2008;104:1531\u20133.","journal-title":"J Appl Physiol"},{"key":"2239_CR41","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1152\/japplphysiol.01092.2007a","volume":"104","author":"R Glenny","year":"2008","unstructured":"Glenny R. Counterpoint: gravity is not the major factor determining the distribution of blood flow in the healthy human lung. J Appl Physiol. 2008;104:1533\u20135.","journal-title":"J Appl Physiol"},{"key":"2239_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1152\/japplphysiol.01531.2012","volume":"115","author":"AC Henderson","year":"2013","unstructured":"Henderson AC, S\u00e1 RC, Theilmann RJ, Buxton RB, Prisk GK, Hopkins SR. The gravitational distribution of ventilation-perfusion ratio is more uniform in prone than supine posture in the normal human lung. J Appl Physiol. 2013;115:313\u201324.","journal-title":"J Appl Physiol"},{"key":"2239_CR43","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0140-6736(96)90011-2","volume":"347","author":"JA Barber\u00e0","year":"1996","unstructured":"Barber\u00e0 JA, Roger N, Roca J, Rodriguez-Roisin R, Rovira I, Higenbottam TW. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet. 1996;347:436\u201340.","journal-title":"Lancet"},{"key":"2239_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/thx.52.2.120","volume":"52","author":"Y Katayama","year":"1997","unstructured":"Katayama Y, Higenbottam TW, DiazdeAtauri MJ, Cremona G, Akamine S, Barbera JA, et al. Inhaled nitric oxide and arterial oxygen tension in patients with chronic obstructive pulmonary disease and severe pulmonary hypertension. Thorax. 1997;52:120\u20134.","journal-title":"Thorax"},{"key":"2239_CR45","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1164\/ajrccm.156.2.9606016","volume":"156","author":"J Card\u00fas","year":"1997","unstructured":"Card\u00fas J, Burgos F, Diaz O, Roca J, Barber\u00e1 JA, Marrades RM, et al. Increase in pulmonary ventilation-perfusion inequality with age in healthy individuals. Am J Respir Crit Care Med. 1997;156:648\u201353.","journal-title":"Am J Respir Crit Care Med"},{"issue":"123","key":"2239_CR46","first-page":"136","volume":"2017","author":"RC S\u00e1","year":"1985","unstructured":"S\u00e1 RC, Henderson AC, Simonson T, Arai TJ, Wagner H, Theilmann RJ, et al. Measurement of the distribution of ventilation-perfusion ratios in the human lung with proton MRI: comparison with the multiple inert-gas elimination technique. J Appl Physiol Bethesda Md. 1985;2017(123):136\u201346.","journal-title":"J Appl Physiol Bethesda Md"},{"key":"2239_CR47","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1152\/japplphysiol.00072.2013","volume":"115","author":"M Kretzschmar","year":"2013","unstructured":"Kretzschmar M, Schilling T, Vogt A, Rothen HU, Borges JB, Hachenberg T, et al. Multiple inert gas elimination technique by micropore membrane inlet mass spectrometry\u2014a comparison with reference gas chromatography. J Appl Physiol. 2013;115:1107\u201318.","journal-title":"J Appl Physiol"},{"key":"2239_CR48","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1164\/rccm.200409-1296OC","volume":"171","author":"MF Vidal Melo","year":"2005","unstructured":"Vidal Melo MF, Harris RS, Layfield JDH, Venegas JG. Topographic basis of bimodal ventilation-perfusion distributions during bronchoconstriction in sheep. Am J Respir Crit Care Med. 2005;171:714\u201321.","journal-title":"Am J Respir Crit Care Med"},{"key":"2239_CR49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.resp.2007.03.003","volume":"158","author":"T Bratel","year":"2007","unstructured":"Bratel T, Lagerstrand L, Brodin L-A, Nowak J, Randmaa I. Ventilation-perfusion relationships in pulmonary arterial hypertension: effect of intravenous and inhaled prostacyclin treatment. Respir Physiol Neurobiol. 2007;158:59\u201369.","journal-title":"Respir Physiol Neurobiol"},{"key":"2239_CR50","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1172\/JCI109542","volume":"64","author":"DR Dantzker","year":"1979","unstructured":"Dantzker DR, Bower JS. Mechanisms of gas exchange abnormality in patients with chronic obliterative pulmonary vascular disease. J Clin Invest. 1979;64:1050\u20135.","journal-title":"J Clin Invest"},{"key":"2239_CR51","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1378\/chest.83.2.203","volume":"83","author":"C M\u00e9lot","year":"1983","unstructured":"M\u00e9lot C, Naeije R, Mols P, Vandenbossche JL, Denolin H. Effects of nifedipine on ventilation\/perfusion matching in primary pulmonary hypertension. Chest. 1983;83:203\u20137.","journal-title":"Chest"},{"key":"2239_CR52","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pupt.2008.11.009","volume":"22","author":"R Voswinckel","year":"2009","unstructured":"Voswinckel R, Reichenberger F, Gall H, Schmehl T, Gessler T, Schermuly RT, et al. Metered dose inhaler delivery of treprostinil for the treatment of pulmonary hypertension. Pulm Pharmacol Ther. 2009;22:50\u20136.","journal-title":"Pulm Pharmacol Ther"},{"key":"2239_CR53","doi-asserted-by":"publisher","first-page":"10380","DOI":"10.1038\/s41598-020-67196-y","volume":"10","author":"J Nickander","year":"2020","unstructured":"Nickander J, Themudo R, Sigfridsson A, Xue H, Kellman P, Ugander M. Females have higher myocardial perfusion, blood volume and extracellular volume compared to males\u2014an adenosine stress cardiovascular magnetic resonance study. Sci Rep. 2020;10:10380.","journal-title":"Sci Rep"},{"key":"2239_CR54","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00380-018-1140-6","volume":"33","author":"K Kozu","year":"2018","unstructured":"Kozu K, Sugimura K, Aoki T, Tatebe S, Yamamoto S, Yaoita N, et al. Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension. Heart Vessels. 2018;33:939\u201347.","journal-title":"Heart Vessels"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02239-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02239-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02239-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:22:52Z","timestamp":1669900972000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02239-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2239"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02239-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.08.16.22278842","asserted-by":"object"}]},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"5 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of the Massachusetts General Hospital. Informed consent was obtained from each subject before the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. For full disclosure, ASW has been consulting for United Therapeutics in the past on topics unrelated to this study, and RC has or had consultant, research, or speaker relationships with United Therapeutics, Janssen, Bayer, Gossamer, Altavant, Third Pole, and Aria CV.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"325"}}